LONDON, April 15 (Reuters) - The world's first genetic test to assess the risk of individuals developing type 2 diabetes has been launched by Iceland's Decode Genetics Inc. . The biotech company, ...
Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and ...
The study is part of the PsychENCODE Consortium, which brings together multidisciplinary teams to generate large-scale gene expression and regulatory data from human brains across several major ...
Researchers at the Icelandic biotechnology company DeCode Genetics Incorporated said they found a gene that can double the risk of type 2 diabetes, a disease that affects at least 171 million people ...
SAN FRANCISCO, California, USA, 8 July 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive ...
Researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs. LMU researchers have investigated how cationic polymers organize on a molecular level ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback